반응식
[CH2:1]([C:5]1[N:6]=[C:7]([NH2:10])[S:8][CH:9]=1)[CH2:2][CH2:3][CH3:4].[Cl:11][C:12]1[C:13]([CH3:22])=[C:14]([S:18](Cl)(=[O:20])=[O:19])[CH:15]=[CH:16][CH:17]=1>>[CH2:1]([C:5]1[N:6]=[C:7]([NH:10][S:18]([C:14]2[CH:15]=[CH:16][CH:17]=[C:12]([Cl:11])[C:13]=2[CH3:22])(=[O:19])=[O:20])[S:8][CH:9]=1)[CH2:2][CH2:3][CH3:4]참가 물질
3
실험 절차
The title compound was prepared from 4-butyl-1,3-thiazol-2-ylamine (METHOD H) and 3-chloro-2-methylbenzenesulfonyl chloride according to METHOD A, yellow solid, 52 mg (22% yield): HRMS Calcd (found) for C14H17ClN2O2S2 m/z 344.0420 (334.0414).
출처 및 근거
- ORD 기록
- ord-91d9d7edf35e4796917fccc7089b170c
- 출처 데이터셋
- uspto-grants-2006_10
- 특허 번호
- US07125900B2
연결된 노트
불러오는 중…